Hyperhomocysteinemia Exaggerates Adventitial Inflammation and Angiotensin II−Induced Abdominal Aortic Aneurysm in Mice
RATIONALE:A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist. In addition, we lack direct evidence supporting a causal role. OBJECTIVE:We determined the association and contribution of HHcy to...
Saved in:
Published in | Circulation research Vol. 111; no. 10; pp. 1261 - 1273 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
American Heart Association, Inc
26.10.2012
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | RATIONALE:A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist. In addition, we lack direct evidence supporting a causal role.
OBJECTIVE:We determined the association and contribution of HHcy to AAA formation.
METHODS AND RESULTS:We first performed a meta-analysis of studies involving 1489 subjects and found a strong association of HHcy and AAA (odds ratio, 7.39). Next, we used angiotensin II–infused male apolipoprotein E–deficient mice and tested whether HHcy contributes to AAA pathogenesis. Homocysteine (Hcy) supplement (1.8 g/L) in drinking water resulted in mild HHcy. Intriguingly, HHcy greatly increased the incidence of angiotensin II–induced AAA and aortic dissection in apolipoprotein E–deficient mice (vehicle versus Hcy50% versus 100%; P<0.05). Histology indicated HHcy markedly exaggerated aortic adventitial inflammation. Increased levels of proinflammatory interleukin-6 and monocyte chemoattractant protein-1 were preferentially colocalized within adventitial fibroblasts in HHcy plus angiotensin II mice, which suggested the importance of adventitial fibroblasts activation in Hcy-aggravated AAA. Hcy sequentially stimulated adventitial fibroblasts transformation into myofibroblasts, secretion of interleukin-6 and monocyte chemoattractant protein-1, and consequent recruitment of monocytes/macrophages to adventitial fibroblasts, which was abolished by the NADPH oxidase inhibitor diphenyliodonium. NADPH oxidase 4, but not other homologs of NADPH oxidase, was significantly upregulated by Hcy in adventitial fibroblasts, whereas NADPH oxidase 4 small interfering RNA silencing diminished Hcy-induced adventitial fibroblasts activation. Finally, folic acid supplement (0.071 μg/g per day) markedly reduced HHcy-aggravated angiotensin II–induced AAA formation in apolipoprotein E–deficient mice.
CONCLUSIONS:HHcy may aggravate AAA formation at least partially via activating adventitial fibroblast NADPH oxidase 4. |
---|---|
AbstractList | RATIONALE:A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist. In addition, we lack direct evidence supporting a causal role.
OBJECTIVE:We determined the association and contribution of HHcy to AAA formation.
METHODS AND RESULTS:We first performed a meta-analysis of studies involving 1489 subjects and found a strong association of HHcy and AAA (odds ratio, 7.39). Next, we used angiotensin II–infused male apolipoprotein E–deficient mice and tested whether HHcy contributes to AAA pathogenesis. Homocysteine (Hcy) supplement (1.8 g/L) in drinking water resulted in mild HHcy. Intriguingly, HHcy greatly increased the incidence of angiotensin II–induced AAA and aortic dissection in apolipoprotein E–deficient mice (vehicle versus Hcy50% versus 100%; P<0.05). Histology indicated HHcy markedly exaggerated aortic adventitial inflammation. Increased levels of proinflammatory interleukin-6 and monocyte chemoattractant protein-1 were preferentially colocalized within adventitial fibroblasts in HHcy plus angiotensin II mice, which suggested the importance of adventitial fibroblasts activation in Hcy-aggravated AAA. Hcy sequentially stimulated adventitial fibroblasts transformation into myofibroblasts, secretion of interleukin-6 and monocyte chemoattractant protein-1, and consequent recruitment of monocytes/macrophages to adventitial fibroblasts, which was abolished by the NADPH oxidase inhibitor diphenyliodonium. NADPH oxidase 4, but not other homologs of NADPH oxidase, was significantly upregulated by Hcy in adventitial fibroblasts, whereas NADPH oxidase 4 small interfering RNA silencing diminished Hcy-induced adventitial fibroblasts activation. Finally, folic acid supplement (0.071 μg/g per day) markedly reduced HHcy-aggravated angiotensin II–induced AAA formation in apolipoprotein E–deficient mice.
CONCLUSIONS:HHcy may aggravate AAA formation at least partially via activating adventitial fibroblast NADPH oxidase 4. A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist. In addition, we lack direct evidence supporting a causal role. We determined the association and contribution of HHcy to AAA formation. We first performed a meta-analysis of studies involving 1489 subjects and found a strong association of HHcy and AAA (odds ratio, 7.39). Next, we used angiotensin II-infused male apolipoprotein E-deficient mice and tested whether HHcy contributes to AAA pathogenesis. Homocysteine (Hcy) supplement (1.8 g/L) in drinking water resulted in mild HHcy. Intriguingly, HHcy greatly increased the incidence of angiotensin II-induced AAA and aortic dissection in apolipoprotein E-deficient mice (vehicle versus Hcy: 50% versus 100%; P<0.05). Histology indicated HHcy markedly exaggerated aortic adventitial inflammation. Increased levels of proinflammatory interleukin-6 and monocyte chemoattractant protein-1 were preferentially colocalized within adventitial fibroblasts in HHcy plus angiotensin II mice, which suggested the importance of adventitial fibroblasts activation in Hcy-aggravated AAA. Hcy sequentially stimulated adventitial fibroblasts transformation into myofibroblasts, secretion of interleukin-6 and monocyte chemoattractant protein-1, and consequent recruitment of monocytes/macrophages to adventitial fibroblasts, which was abolished by the NADPH oxidase inhibitor diphenyliodonium. NADPH oxidase 4, but not other homologs of NADPH oxidase, was significantly upregulated by Hcy in adventitial fibroblasts, whereas NADPH oxidase 4 small interfering RNA silencing diminished Hcy-induced adventitial fibroblasts activation. Finally, folic acid supplement (0.071 μg/g per day) markedly reduced HHcy-aggravated angiotensin II-induced AAA formation in apolipoprotein E-deficient mice. HHcy may aggravate AAA formation at least partially via activating adventitial fibroblast NADPH oxidase 4. A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist. In addition, we lack direct evidence supporting a causal role.RATIONALEA number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist. In addition, we lack direct evidence supporting a causal role.We determined the association and contribution of HHcy to AAA formation.OBJECTIVEWe determined the association and contribution of HHcy to AAA formation.We first performed a meta-analysis of studies involving 1489 subjects and found a strong association of HHcy and AAA (odds ratio, 7.39). Next, we used angiotensin II-infused male apolipoprotein E-deficient mice and tested whether HHcy contributes to AAA pathogenesis. Homocysteine (Hcy) supplement (1.8 g/L) in drinking water resulted in mild HHcy. Intriguingly, HHcy greatly increased the incidence of angiotensin II-induced AAA and aortic dissection in apolipoprotein E-deficient mice (vehicle versus Hcy: 50% versus 100%; P<0.05). Histology indicated HHcy markedly exaggerated aortic adventitial inflammation. Increased levels of proinflammatory interleukin-6 and monocyte chemoattractant protein-1 were preferentially colocalized within adventitial fibroblasts in HHcy plus angiotensin II mice, which suggested the importance of adventitial fibroblasts activation in Hcy-aggravated AAA. Hcy sequentially stimulated adventitial fibroblasts transformation into myofibroblasts, secretion of interleukin-6 and monocyte chemoattractant protein-1, and consequent recruitment of monocytes/macrophages to adventitial fibroblasts, which was abolished by the NADPH oxidase inhibitor diphenyliodonium. NADPH oxidase 4, but not other homologs of NADPH oxidase, was significantly upregulated by Hcy in adventitial fibroblasts, whereas NADPH oxidase 4 small interfering RNA silencing diminished Hcy-induced adventitial fibroblasts activation. Finally, folic acid supplement (0.071 μg/g per day) markedly reduced HHcy-aggravated angiotensin II-induced AAA formation in apolipoprotein E-deficient mice.METHODS AND RESULTSWe first performed a meta-analysis of studies involving 1489 subjects and found a strong association of HHcy and AAA (odds ratio, 7.39). Next, we used angiotensin II-infused male apolipoprotein E-deficient mice and tested whether HHcy contributes to AAA pathogenesis. Homocysteine (Hcy) supplement (1.8 g/L) in drinking water resulted in mild HHcy. Intriguingly, HHcy greatly increased the incidence of angiotensin II-induced AAA and aortic dissection in apolipoprotein E-deficient mice (vehicle versus Hcy: 50% versus 100%; P<0.05). Histology indicated HHcy markedly exaggerated aortic adventitial inflammation. Increased levels of proinflammatory interleukin-6 and monocyte chemoattractant protein-1 were preferentially colocalized within adventitial fibroblasts in HHcy plus angiotensin II mice, which suggested the importance of adventitial fibroblasts activation in Hcy-aggravated AAA. Hcy sequentially stimulated adventitial fibroblasts transformation into myofibroblasts, secretion of interleukin-6 and monocyte chemoattractant protein-1, and consequent recruitment of monocytes/macrophages to adventitial fibroblasts, which was abolished by the NADPH oxidase inhibitor diphenyliodonium. NADPH oxidase 4, but not other homologs of NADPH oxidase, was significantly upregulated by Hcy in adventitial fibroblasts, whereas NADPH oxidase 4 small interfering RNA silencing diminished Hcy-induced adventitial fibroblasts activation. Finally, folic acid supplement (0.071 μg/g per day) markedly reduced HHcy-aggravated angiotensin II-induced AAA formation in apolipoprotein E-deficient mice.HHcy may aggravate AAA formation at least partially via activating adventitial fibroblast NADPH oxidase 4.CONCLUSIONSHHcy may aggravate AAA formation at least partially via activating adventitial fibroblast NADPH oxidase 4. |
Author | Huang, Yaqian Zheng, Jingang Liu, Ziyi Zhu, Yi Xie, Jinsheng Luo, Hongzhi Ma, Kongyang Hu, Jing Kong, Wei Liu, Bo Zhang, Lu Feng, Juan Xu, Qingbo Zhan, Siyan Wang, Xian |
AuthorAffiliation | From the Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P. R. China (Z.L, H.L., Y.H., B.L., K.M., J.F., Y.Z., W.K., X.W.); Department of Vascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, P. R. China (J.X.); Department of Cardiology, China-Japan Friendship Hospital, Beijing, P. R. China (J.Z.); Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, P. R. China (J.H., S.Z.); Cardiovascular Division, Kings College London BHF Centre, London, United Kingdom (Q.X.) |
AuthorAffiliation_xml | – name: From the Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P. R. China (Z.L, H.L., Y.H., B.L., K.M., J.F., Y.Z., W.K., X.W.); Department of Vascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, P. R. China (J.X.); Department of Cardiology, China-Japan Friendship Hospital, Beijing, P. R. China (J.Z.); Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, P. R. China (J.H., S.Z.); Cardiovascular Division, Kings College London BHF Centre, London, United Kingdom (Q.X.) |
Author_xml | – sequence: 1 givenname: Ziyi surname: Liu fullname: Liu, Ziyi organization: From the Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P. R. China (Z.L, H.L., Y.H., B.L., K.M., J.F., Y.Z., W.K., X.W.); Department of Vascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, P. R. China (J.X.); Department of Cardiology, China-Japan Friendship Hospital, Beijing, P. R. China (J.Z.); Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, P. R. China (J.H., S.Z.); Cardiovascular Division, Kings College London BHF Centre, London, United Kingdom (Q.X.) – sequence: 2 givenname: Hongzhi surname: Luo fullname: Luo, Hongzhi – sequence: 3 givenname: Lu surname: Zhang fullname: Zhang, Lu – sequence: 4 givenname: Yaqian surname: Huang fullname: Huang, Yaqian – sequence: 5 givenname: Bo surname: Liu fullname: Liu, Bo – sequence: 6 givenname: Kongyang surname: Ma fullname: Ma, Kongyang – sequence: 7 givenname: Juan surname: Feng fullname: Feng, Juan – sequence: 8 givenname: Jinsheng surname: Xie fullname: Xie, Jinsheng – sequence: 9 givenname: Jingang surname: Zheng fullname: Zheng, Jingang – sequence: 10 givenname: Jing surname: Hu fullname: Hu, Jing – sequence: 11 givenname: Siyan surname: Zhan fullname: Zhan, Siyan – sequence: 12 givenname: Yi surname: Zhu fullname: Zhu, Yi – sequence: 13 givenname: Qingbo surname: Xu fullname: Xu, Qingbo – sequence: 14 givenname: Wei surname: Kong fullname: Kong, Wei – sequence: 15 givenname: Xian surname: Wang fullname: Wang, Xian |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26548142$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22912384$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1u1DAUhS1URKeFRwBlg8QmxT9xfsQqGg1MpCKkAuvIsW9mDI492E7beQPWPCJPgocZqMSGjS3f-x376hxfoDPrLCD0nOArQkryetndLG9WH9t1m870ilaYU_wILQinRV7wipyhBca4ySvG8Dm6COELxqRgtHmCziltCGV1sUD36_0O_NZNTu5DBG1h0iJb3YvNBryIELJW3YKNOmphss6ORkyTiNrZTFiVtXajXQQbtM267uf3H51Vs4TUGJSbtE2a1vmoZSJh9vswZYl8ryU8RY9HYQI8O-2X6PPb1aflOr_-8K5btte5LDgu86EWbFA1L8hAair5gFkzDkqONWZloxJUgGBSUIIryqGCpiZFrUip6jQGqdklenW8d-fdtxlC7CcdJBgjLLg59Mk8WlJaVzyhL07oPEyg-p3Xk_D7_o9bCXh5AkSQwoxeWKnDA1fyIr1OE8ePnPQuBA_jX4Tg_pBe_5DeYYD-mF7SvflHJ3X8bXb0Qpv_qouj-s6ZCD58NfMd-H4LwsRtn_4CZpjQnKaFYFri_FAq2S8oDbGt |
CODEN | CIRUAL |
CitedBy_id | crossref_primary_10_1080_10641963_2023_2205058 crossref_primary_10_3389_fphys_2018_01026 crossref_primary_10_3389_fphar_2018_00496 crossref_primary_10_1080_13813455_2020_1841795 crossref_primary_10_1155_2020_4378505 crossref_primary_10_1080_07853890_2025_2457527 crossref_primary_10_1111_1755_5922_12306 crossref_primary_10_3390_ijms140715074 crossref_primary_10_1111_cge_13705 crossref_primary_10_1080_1061186X_2020_1759077 crossref_primary_10_1038_s41598_017_15079_0 crossref_primary_10_1016_j_avsg_2021_10_031 crossref_primary_10_3390_ijms242115908 crossref_primary_10_3390_ijms22126259 crossref_primary_10_3390_ph16091212 crossref_primary_10_1016_j_clinre_2021_101833 crossref_primary_10_1016_j_atherosclerosis_2013_02_019 crossref_primary_10_1111_bcpt_13524 crossref_primary_10_4251_wjgo_v15_i3_504 crossref_primary_10_1016_j_imbio_2020_151941 crossref_primary_10_1177_1358863X211021170 crossref_primary_10_1007_s00018_020_03607_7 crossref_primary_10_1007_s00109_018_1645_6 crossref_primary_10_3389_fcvm_2022_949262 crossref_primary_10_1111_cbdd_13837 crossref_primary_10_1080_17458080_2022_2060500 crossref_primary_10_1536_ihj_24_483 crossref_primary_10_1161_ATVBAHA_120_315398 crossref_primary_10_1186_s10020_020_00241_8 crossref_primary_10_1093_cvr_cvae093 crossref_primary_10_1016_j_cellsig_2020_109575 crossref_primary_10_1007_s12192_020_01111_2 crossref_primary_10_1152_jn_00477_2022 crossref_primary_10_2337_db18_0098 crossref_primary_10_4081_ejh_2022_3336 crossref_primary_10_1016_j_retram_2022_103352 crossref_primary_10_1159_000510470 crossref_primary_10_3389_fcvm_2020_542519 crossref_primary_10_3760_cma_j_issn_0366_6999_20132795 crossref_primary_10_3389_fcell_2022_882211 crossref_primary_10_1016_j_freeradbiomed_2017_01_025 crossref_primary_10_1161_HYPERTENSIONAHA_120_16738 crossref_primary_10_1186_s10020_022_00584_4 crossref_primary_10_1111_jcmm_70159 crossref_primary_10_1096_fj_201801809R crossref_primary_10_1556_2060_2022_00154 crossref_primary_10_3892_ol_2018_9021 crossref_primary_10_1016_j_bbadis_2015_11_015 crossref_primary_10_1016_j_gene_2023_148036 crossref_primary_10_1016_j_biochi_2020_02_012 crossref_primary_10_3390_nu14071412 crossref_primary_10_1371_journal_pone_0164015 crossref_primary_10_1093_cvr_cvz288 crossref_primary_10_1016_j_carpath_2017_01_008 crossref_primary_10_1038_s41598_022_25369_x crossref_primary_10_1177_1559325820926765 crossref_primary_10_3390_nu15143186 crossref_primary_10_1016_j_acra_2023_04_027 crossref_primary_10_1080_08977194_2022_2077732 crossref_primary_10_1016_j_yjmcc_2022_06_010 crossref_primary_10_1016_j_bej_2021_108172 crossref_primary_10_1016_j_thromres_2018_07_014 crossref_primary_10_1177_1358863X17718260 crossref_primary_10_1097_MPA_0000000000002047 crossref_primary_10_1161_ATVBAHA_118_311917 crossref_primary_10_7883_yoken_JJID_2022_622 crossref_primary_10_1038_s41401_019_0308_7 crossref_primary_10_1007_s10863_021_09916_1 crossref_primary_10_1038_s41467_017_02401_7 crossref_primary_10_3390_biom10030393 crossref_primary_10_1016_j_yjmcc_2015_02_026 crossref_primary_10_1155_2020_4691026 crossref_primary_10_3389_fphys_2019_00192 crossref_primary_10_1016_j_bbadis_2020_165912 crossref_primary_10_1111_ijcp_14944 crossref_primary_10_1093_eurjpc_zwad271 crossref_primary_10_3389_fcvm_2021_753711 crossref_primary_10_3390_ijms151119487 crossref_primary_10_1161_ATVBAHA_120_315587 crossref_primary_10_1038_s41598_024_83662_3 crossref_primary_10_1159_000528650 crossref_primary_10_3892_etm_2021_10704 crossref_primary_10_1016_j_jnutbio_2014_10_004 crossref_primary_10_1017_S0952523821000031 crossref_primary_10_1155_2023_6642768 crossref_primary_10_1016_j_omtn_2021_10_031 crossref_primary_10_1007_s10565_021_09622_z crossref_primary_10_1097_MD_0000000000004793 crossref_primary_10_3389_fcvm_2024_1394889 crossref_primary_10_1016_j_jare_2025_02_032 crossref_primary_10_1186_s12872_021_02275_0 crossref_primary_10_1016_j_jvs_2013_01_046 crossref_primary_10_1038_srep17966 crossref_primary_10_1080_08923973_2019_1637890 crossref_primary_10_3390_ijms232012452 crossref_primary_10_1016_j_intimp_2022_109177 crossref_primary_10_1161_ATVBAHA_117_309859 crossref_primary_10_1167_tvst_10_4_20 crossref_primary_10_1159_000530763 crossref_primary_10_1371_journal_pone_0085831 crossref_primary_10_3390_genes12040513 crossref_primary_10_1111_cei_13618 crossref_primary_10_1016_j_mvr_2024_104754 crossref_primary_10_1016_j_yjmcc_2015_02_005 crossref_primary_10_1002_iid3_631 crossref_primary_10_1016_j_ejphar_2021_174168 crossref_primary_10_1055_a_1952_1946 crossref_primary_10_1007_s12325_020_01474_z crossref_primary_10_1074_jbc_RA119_009758 crossref_primary_10_1159_000501313 crossref_primary_10_1111_bph_13988 crossref_primary_10_1186_s42358_021_00175_7 crossref_primary_10_1016_j_phrs_2016_10_015 crossref_primary_10_1161_ATVBAHA_116_307825 crossref_primary_10_1002_bab_2426 crossref_primary_10_1016_j_brainresbull_2025_111272 crossref_primary_10_1016_j_jvs_2013_10_095 crossref_primary_10_1360_SSV_2021_0232 crossref_primary_10_1152_ajpheart_00577_2014 crossref_primary_10_1016_j_vph_2019_01_001 crossref_primary_10_1002_jcb_25941 crossref_primary_10_1152_jn_00466_2021 crossref_primary_10_18632_aging_204121 crossref_primary_10_1159_000508077 |
Cites_doi | 10.1161/circulationaha.107.690982 10.1016/j.cardiores.2007.06.007 10.1160/TH05-06-0431 10.1172/JCI11596 10.1074/jbc.M110.184606 10.1136/jmg.2008.057851 10.1038/labinvest.2008.167 10.1016/j.ejvs.2005.03.009 10.1161/circulationaha.110.000588 10.1056/NEJM199707243370403 10.1093/cvr/cvq337 10.1161/01.CIR.91.4.1161 10.1016/j.ejvs.2003.09.001 10.1093/cvr/cvp182 10.1016/j.cardiores.2007.06.016 10.1159/000320358 10.1373/clinchem.2003.021634 10.1016/j.cardiores.2007.06.023 10.1016/j.atherosclerosis.2006.10.013 10.1067/mva.2000.107563 10.1016/S1078-5884(03)00381-2 10.1093/cvr/cvq224 10.1016/j.jvs.2006.12.019 10.1056/NEJM199104253241701 10.1016/j.freeradbiomed.2009.07.022 10.1016/j.ejvs.2005.02.047 10.1016/j.bbrc.2005.10.207 10.1089/ars.2007.1750 10.1038/ng.744 10.1001/jama.1995.03530130055028 10.1172/JCI38308 10.1073/pnas.94.26.14483 10.1681/ASN.2009020146 10.1001/jama.2010.840 10.2174/138920007779315008 10.1001/jama.2011.1834 10.1016/j.prp.2006.08.008 10.1038/nrcardio.2010.180 10.1111/j.1538-7836.2011.04209.x 10.1016/j.molmed.2008.09.008 10.1161/hh2401.100844 10.1016/S0945-053X(98)90108-1 10.1161/01.res.0000087642.01082.e4 10.1038/ki.2010.516 |
ContentType | Journal Article |
Copyright | 2012 American Heart Association, Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: 2012 American Heart Association, Inc. – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/CIRCRESAHA.112.270520 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4571 |
EndPage | 1273 |
ExternalDocumentID | 22912384 26548142 10_1161_CIRCRESAHA_112_270520 00003012-201210260-00006 |
Genre | Research Support, Non-U.S. Gov't Meta-Analysis Journal Article |
GroupedDBID | --- -~X .-D .3C .Z2 01R 0R~ 18M 1J1 29B 2WC 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AARTV AASOK AAXQO ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACNWC ACPRK ACWDW ACWRI ACXNZ ACZKN ADBBV ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFDTB AFUWQ AGINI AHMBA AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW ALKUP ALMA_UNASSIGNED_HOLDINGS AMJPA AMNEI BAWUL BOYCO BQLVK BYPQX C45 CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GX1 H0~ H13 HZ~ IKREB IKYAY IN~ JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OB2 OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH OUVQU OVD OVDNE OVIDH OVLEI OWW OWY OXXIT P2P PQQKQ RAH RLZ S4R S4S T8P TEORI TR2 UPT V2I VVN W3M W8F WH7 WOQ WOW X3V X3W YFH YOC ZFV ZZMQN AAYXX ADGHP CITATION .55 .GJ 1CY 41~ AAQKA AASCR ABASU ABVCZ ABZZY ACLDA ACXJB ADFPA AFBFQ AFFNX AHRYX AKCTQ AKULP ALMTX AMKUR AOHHW AOQMC BS7 C1A EEVPB ERAAH GNXGY GQDEL HLJTE H~9 IPNFZ IQODW J5H JF9 JG8 MVM N~M OCUKA ODA ORVUJ OWU OWV OWX OWZ P-K R58 RIG TSPGW X7M XXN XYM ZGI ACIJW AWKKM CGR CUY CVF ECM EIF NPM OLW RHF 7X8 |
ID | FETCH-LOGICAL-c4506-b8a3bd8541b182c5b039fbdcf80369dc454ea3ca210725e7e98148d16d8ced183 |
ISSN | 0009-7330 1524-4571 |
IngestDate | Fri Jul 11 06:19:40 EDT 2025 Wed Feb 19 01:49:04 EST 2025 Mon Jul 21 09:14:52 EDT 2025 Tue Jul 01 04:27:43 EDT 2025 Thu Apr 24 22:50:19 EDT 2025 Fri May 16 03:47:18 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | NADPH Enzyme Peptide hormone Rodentia Oxidase Cardiovascular disease Inflammation Aortic aneurysm abdominal aortic aneurysm Octapeptide Renin angiotensin system Vertebrata adventitial fibroblast Mammalia Mouse NADPH oxidase 4 Hyperhomocysteinemia Oxidoreductases Circulatory system Angiotensin II Fibroblast |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4506-b8a3bd8541b182c5b039fbdcf80369dc454ea3ca210725e7e98148d16d8ced183 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 22912384 |
PQID | 1122622875 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1122622875 pubmed_primary_22912384 pascalfrancis_primary_26548142 crossref_primary_10_1161_CIRCRESAHA_112_270520 crossref_citationtrail_10_1161_CIRCRESAHA_112_270520 wolterskluwer_health_00003012-201210260-00006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-October-26 |
PublicationDateYYYYMMDD | 2012-10-26 |
PublicationDate_xml | – month: 10 year: 2012 text: 2012-October-26 day: 26 |
PublicationDecade | 2010 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Circulation research |
PublicationTitleAlternate | Circ Res |
PublicationYear | 2012 |
Publisher | American Heart Association, Inc Lippincott Williams & Wilkins |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott Williams & Wilkins |
References | e_1_3_5_28_2 e_1_3_5_27_2 e_1_3_5_26_2 e_1_3_5_25_2 e_1_3_5_24_2 e_1_3_5_23_2 e_1_3_5_22_2 e_1_3_5_21_2 e_1_3_5_43_2 e_1_3_5_44_2 e_1_3_5_45_2 e_1_3_5_46_2 e_1_3_5_47_2 e_1_3_5_48_2 e_1_3_5_49_2 e_1_3_5_29_2 e_1_3_5_2_2 e_1_3_5_40_2 e_1_3_5_41_2 e_1_3_5_42_2 e_1_3_5_8_2 e_1_3_5_9_2 e_1_3_5_4_2 e_1_3_5_3_2 e_1_3_5_6_2 e_1_3_5_5_2 e_1_3_5_17_2 e_1_3_5_39_2 e_1_3_5_16_2 e_1_3_5_38_2 e_1_3_5_15_2 e_1_3_5_37_2 e_1_3_5_36_2 Giusti B (e_1_3_5_7_2) 2004; 50 e_1_3_5_12_2 e_1_3_5_35_2 e_1_3_5_13_2 e_1_3_5_34_2 e_1_3_5_10_2 Koch AE (e_1_3_5_20_2) 1990; 137 e_1_3_5_33_2 e_1_3_5_11_2 e_1_3_5_32_2 e_1_3_5_19_2 e_1_3_5_18_2 e_1_3_5_31_2 e_1_3_5_30_2 Strauss E (e_1_3_5_14_2) 2003; 44 |
References_xml | – ident: e_1_3_5_19_2 doi: 10.1161/circulationaha.107.690982 – ident: e_1_3_5_40_2 doi: 10.1016/j.cardiores.2007.06.007 – ident: e_1_3_5_9_2 doi: 10.1160/TH05-06-0431 – ident: e_1_3_5_36_2 doi: 10.1172/JCI11596 – ident: e_1_3_5_45_2 doi: 10.1074/jbc.M110.184606 – ident: e_1_3_5_15_2 doi: 10.1136/jmg.2008.057851 – ident: e_1_3_5_23_2 doi: 10.1038/labinvest.2008.167 – ident: e_1_3_5_3_2 doi: 10.1016/j.ejvs.2005.03.009 – ident: e_1_3_5_26_2 doi: 10.1161/circulationaha.110.000588 – ident: e_1_3_5_6_2 doi: 10.1056/NEJM199707243370403 – ident: e_1_3_5_4_2 doi: 10.1093/cvr/cvq337 – ident: e_1_3_5_28_2 doi: 10.1161/01.CIR.91.4.1161 – ident: e_1_3_5_8_2 doi: 10.1016/j.ejvs.2003.09.001 – ident: e_1_3_5_32_2 doi: 10.1093/cvr/cvp182 – ident: e_1_3_5_41_2 doi: 10.1016/j.cardiores.2007.06.016 – ident: e_1_3_5_22_2 doi: 10.1159/000320358 – volume: 44 start-page: 85 year: 2003 ident: e_1_3_5_14_2 article-title: Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele. publication-title: J Appl Genet – ident: e_1_3_5_30_2 doi: 10.1373/clinchem.2003.021634 – ident: e_1_3_5_38_2 doi: 10.1016/j.cardiores.2007.06.023 – ident: e_1_3_5_31_2 doi: 10.1016/j.atherosclerosis.2006.10.013 – ident: e_1_3_5_11_2 doi: 10.1067/mva.2000.107563 – ident: e_1_3_5_10_2 doi: 10.1016/S1078-5884(03)00381-2 – ident: e_1_3_5_18_2 doi: 10.1093/cvr/cvq224 – ident: e_1_3_5_12_2 doi: 10.1016/j.jvs.2006.12.019 – ident: e_1_3_5_24_2 doi: 10.1056/NEJM199104253241701 – ident: e_1_3_5_43_2 doi: 10.1016/j.freeradbiomed.2009.07.022 – ident: e_1_3_5_13_2 doi: 10.1016/j.ejvs.2005.02.047 – ident: e_1_3_5_42_2 doi: 10.1016/j.bbrc.2005.10.207 – ident: e_1_3_5_46_2 doi: 10.1089/ars.2007.1750 – ident: e_1_3_5_48_2 doi: 10.1038/ng.744 – ident: e_1_3_5_5_2 doi: 10.1001/jama.1995.03530130055028 – ident: e_1_3_5_21_2 doi: 10.1172/JCI38308 – ident: e_1_3_5_44_2 doi: 10.1073/pnas.94.26.14483 – ident: e_1_3_5_49_2 doi: 10.1681/ASN.2009020146 – ident: e_1_3_5_25_2 doi: 10.1001/jama.2010.840 – ident: e_1_3_5_35_2 doi: 10.2174/138920007779315008 – ident: e_1_3_5_27_2 doi: 10.1001/jama.2011.1834 – ident: e_1_3_5_37_2 doi: 10.1016/j.prp.2006.08.008 – ident: e_1_3_5_16_2 doi: 10.1038/nrcardio.2010.180 – ident: e_1_3_5_2_2 doi: 10.1038/nrcardio.2010.180 – ident: e_1_3_5_17_2 doi: 10.1111/j.1538-7836.2011.04209.x – ident: e_1_3_5_34_2 doi: 10.1016/j.molmed.2008.09.008 – ident: e_1_3_5_39_2 doi: 10.1161/hh2401.100844 – volume: 137 start-page: 1199 year: 1990 ident: e_1_3_5_20_2 article-title: Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. publication-title: Am J Pathol – volume: 50 start-page: 945 year: 2004 ident: e_1_3_5_7_2 article-title: Role of hyperhomocysteinemia in aortic disease. publication-title: Cell Mol Biol (Noisy-le-grand) – ident: e_1_3_5_29_2 doi: 10.1016/S0945-053X(98)90108-1 – ident: e_1_3_5_33_2 doi: 10.1161/01.res.0000087642.01082.e4 – ident: e_1_3_5_47_2 doi: 10.1038/ki.2010.516 |
SSID | ssj0014329 |
Score | 2.4642131 |
SecondaryResourceType | review_article |
Snippet | RATIONALE:A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but... A number of epidemiological studies have suggested an association of hyperhomocysteinemia (HHcy) and abdominal aortic aneurysm (AAA), but discrepancies exist.... |
SourceID | proquest pubmed pascalfrancis crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1261 |
SubjectTerms | Adventitia - immunology Angiotensin II - pharmacology Animals Aortic Aneurysm, Abdominal - chemically induced Aortic Aneurysm, Abdominal - epidemiology Aortic Aneurysm, Abdominal - immunology Apolipoproteins E - genetics Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Chemokine CCL2 - secretion Disease Models, Animal Diseases of the aorta Female Fibroblasts - enzymology Fibroblasts - immunology Fibroblasts - secretion Fundamental and applied biological sciences. Psychology Humans Hyperhomocysteinemia - epidemiology Hyperhomocysteinemia - immunology Hyperhomocysteinemia - metabolism Incidence Interleukin-6 - secretion Male Medical sciences Mice Mice, Mutant Strains Middle Aged NADPH Oxidase 4 NADPH Oxidases - metabolism Reactive Oxygen Species - metabolism Risk Factors Signal Transduction - immunology Smad2 Protein - metabolism Smad3 Protein - metabolism Vasculitis - epidemiology Vasculitis - immunology Vasculitis - metabolism Vasoconstrictor Agents - pharmacology Vertebrates: cardiovascular system |
Title | Hyperhomocysteinemia Exaggerates Adventitial Inflammation and Angiotensin II−Induced Abdominal Aortic Aneurysm in Mice |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003012-201210260-00006 https://www.ncbi.nlm.nih.gov/pubmed/22912384 https://www.proquest.com/docview/1122622875 |
Volume | 111 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELZgkRASQtyUY2Uk3iqX2nWux6oCtWiXB7QrlafITpxutDQpbcOxv57xUSeFIo6XqHFjR8r3ZeKxZ75B6FUoFVdhwQnNlSRcBDmRKokIZSIXYaYinusd3dP34fScv5sH83ZN12SXbOUguzqYV_I_qEIb4KqzZP8BWT8oNMBvwBeOgDAc_wrjKTiR64t6WWdajxnmi8tS9NU3sVhoqWSl9ZqsPpOpzFEVgL7NVHQSrYuyNgHsVX82I-CcNzoYQMi8tpW-RL22cq4KHvxmqZdGli5UzosblOvMFQDrO90gv758UjZm66P8XvqmxqzMTutqcXXhW_2i9UnTssw1fRSfdwR2axOUaaPOnLK1s6eMEx7YKive4Drz6pg17NhPyqw0-6-GPdSGfTL7MAFijqdjnfo0YJGO4uleD_islgZtxhL4KNvycz8pau_-uo5uMHAuTIr43AcGwQSSJS7XC-76-uA9tYa0G2VvQnN7JTbwbhW2KMohrwWu-VrrQIjNpcmD6Mxmzu6iO84NwWPLqXvomqruo5unLtDiAfpyiFq4Qy3coRbuUgsDtXCHWrilFvbUwpZaeEctGAFraj1E52_fnE2mxJXoIBkPhiGRsRjJPA44leCoZoEcjpJC5lkRw8woyeEirsQoE4wOIxaoSCUx-N85DfMYbgufk0foqKor9QRhzgqVwQckYCrnURglxTDJ4ohROAUvXvYQ3z3nNHP69bqMyqfU-LEhTVuk4JylFqkeGvhuKyvg8qcOx3sg-l4sBO-ectZDL3eopmCL9QYbPK262ehBWMhYHAU99NjC3fZ2dOkhsod_avOddRCIXp1gRL9HVCv9ETOXfPrbkZ6hW-079xwdbdeNegEz5K08NoT-AXDmu6g |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperhomocysteinemia+exaggerates+adventitial+inflammation+and+angiotensin+II-induced+abdominal+aortic+aneurysm+in+mice&rft.jtitle=Circulation+research&rft.au=Liu%2C+Ziyi&rft.au=Luo%2C+Hongzhi&rft.au=Zhang%2C+Lu&rft.au=Huang%2C+Yaqian&rft.date=2012-10-26&rft.eissn=1524-4571&rft.volume=111&rft.issue=10&rft.spage=1261&rft_id=info:doi/10.1161%2FCIRCRESAHA.112.270520&rft_id=info%3Apmid%2F22912384&rft.externalDocID=22912384 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon |